Elevance Health Reports Strong Q3 Earnings and Raises FY2026 Guidance
Elevance Health, a leading health benefits company, exceeded expectations in its third-quarter financial results. The firm reported non-GAAP earnings per share (EPS) of $6.99 for the quarter, surpassing forecasts by $2.30. Revenue reached $50.4 billion, up 0.6% year-over-year and beating estimates by over a billion dollars. The company also raised its full-year 2026 adjusted diluted EPS guidance to at least $29.00 from the previous target of $27.00—well above the consensus estimate of $27.24. This update reflects confidence in continued performance and operational improvements, which could bolster investor sentiment. The results highlight Elevance Health's ability to manage costs effectively while maintaining revenue growth amid a challenging economic environment.
Tickers: $ELV
Topics: Earnings Guidance Update
Read the full article at Seeking Alpha
Part of the story Equinix Reports Strong Q3 2026 Results and Raises Full-Year Guidance (49 articles)